Nantahala Capital Management, LLC

Holdings History for Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

Symbol: QNCX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 par value
Latest Disclosed Shares Owned: 5,620,422 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Nantahala Capital Management, LLC ownership in Quince Therapeutics, Inc. Common Stock, par value $0.0001 par value (QNCX)

14 Nov 2025 - Nantahala Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,620,422 shares of Quince Therapeutics, Inc. Common Stock, par value $0.0001 par value (QNCX). This represents 10% ownership of the company. In their previous filing dated 14 Aug 2025, Nantahala Capital Management, LLC had reported owning 4,765,862 shares, indicating an increase of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Nantahala Capital Management, LLC	10%	0%	$9,156,792	5,620,422	+854,560	+18%	$1.63	13G/A	30 Sep 2025	14 Nov 2025, 16:32
Nantahala Capital Management, LLC	10%		$8,149,624	4,765,862			$1.71	13G	30 Jun 2025	14 Aug 2025, 16:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.53%	-0.08%	$8,952,637	2,672,429	-401,300	-13%	$3.35	Q4 2025
30 Sep 2025	0.31%	+0.05%	$5,010,178	3,073,729	+545,427	+22%	$1.63	Q3 2025
30 Jun 2025	0.3%	+0.3%	$4,171,698	2,528,302	+2,528,302	NEW	$1.65	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.